Skip to content

PharmaDEXI

Active
Private limited companyfounded 2021active for 5 yearsNotarisstraat 64, 1050 Elsene, BelgiumKBO/BCE: BE 0771.461.685
Summary

The computed 12-month bankruptcy probability of PharmaDEXI is 13.5% (high). For PharmaDEXI, at least two annual filings are missing. The 2023 annual accounts show negative equity (-€40,156) and a net result of -€14,540. The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Overview

Official details

Source: KBO
Status
Active since 15-07-2021 Normal situation
Registered office
13 active companies are registered at this address 2 started in the 12 months before. Source: KBO register, as of 3 November 2026.
Activity
No activity registered in the KBO
Establishment unit
2.320.278.404 1050 Elsene, since 15-07-2021
Financial year end
31 December
Peppol
Not found in the Peppol Directory

Board and ownership

Board
  • RABEMANANTSOA ANDRYDirector · since 21-07-2021

Financial position

Bankruptcy probabilitywithin 12 months
13.5%
2023 figures too old to score
Annual accounts 2023
Gross margin
-€9,252
▲ 41.9%
Loss
€14,540
▼ 52.5%
Equity
-€40,156
▼ 56.8%
Total assets
€29,457
▼ 6.4%
  • Negative equity on 31-12-2023
  • 2024 accounts not filed, 460 days past the deadline
Turnover not published (micro format)
Signalsraises riskFigures for financial year 2023 (filed on 30-08-2024)No filing in 24 months (latest 30-08-2024)No main activity registeredTwo or more financial years not filed2023 accounts filed 30 days latelowers riskSize: total assets €29,457Show the evidence

Bankruptcy probability

No current score
Figures too old
The latest figures are for FY 2023. They are too old for a current score.
Bankruptcy probability: High
Filing: At least two annual filings are missing
Financial strength, FY 2023 · tick: 2022
Weak
Solvency 0=
equity -136.3% of total assets
Liquidity 7+7
short-term debt 236.3% · cash 5.6%
Profitability 0=
return on assets -49.4%
Bankruptcy probability within 12 months
13.5% High
0%0.5%1.5%4%10%≥ 25%

About 1 in 7 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 3.6% 01-2025: 3.6%● unchanged vs 12-2024lowest value 02-2025: 3.7%▲ +0.1 percentage points vs 01-2025 03-2025: 3.7%● unchanged vs 02-2025 04-2025: 3.8%▲ +0.1 percentage points vs 03-2025 05-2025: 3.8%● unchanged vs 04-2025 06-2025: 3.9%▲ +0.1 percentage points vs 05-2025 07-2025: 3.9%● unchanged vs 06-2025 08-2025: 5.0%▲ +1.1 percentage points vs 07-2025 09-2025: 5.5%▲ +0.5 percentage points vs 08-2025 10-2025: 7.6%▲ +2.1 percentage points vs 09-2025 11-2025: 7.7%▲ +0.1 percentage points vs 10-2025 12-2025: 8.7%▲ +1.0 percentage point vs 11-2025 01-2026: 10.6%▲ +1.9 percentage points vs 12-2025 02-2026: 10.6%● unchanged vs 01-2026 03-2026: 10.6%● unchanged vs 02-2026 04-2026: 10.2%▼ -0.4 percentage points vs 03-2026 05-2026: 10.2%● unchanged vs 04-2026 06-2026: 10.0%▼ -0.2 percentage points vs 05-2026 07-2026: 9.7%▼ -0.3 percentage points vs 06-2026 08-2026: 10.0%▲ +0.3 percentage points vs 07-2026 09-2026: 13.7%▲ +3.7 percentage points vs 08-2026highest value 10-2026: 13.5%▼ -0.2 percentage points vs 09-2026 11-2026: 13.5%● unchanged vs 10-2026
Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
raises risk · Figures for financial year 2023 (filed on 30-08-2024)
NBB · annual accounts
raises risk · No filing in 24 months (latest 30-08-2024)
NBB · filings
lowers risk · Size: total assets €29,457
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · No main activity registered
KBO
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2024, 2 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 2 filings
Position against the passed deadline
31-12-2024 year end31-07-2025 deadline03-11-2026 today
raises risk · 2023 accounts filed 30 days late
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 30-08-2024, 30 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 2 filings
Deviation from the deadline
2025
not filed
2024
not filed
2023
30 days late
2022
14 days late
← before the deadline after the deadline →
tick = median of all Belgian filings

The company filed its last 2 accounts on average 22 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Financials

Financials · financial year 2023, micro format

2024 annual accounts not yet filed, deadline passed on 31 July 2025 The financial year closed on 31 December 2024. The accounts are due at the latest 7 months after the close (Companies Code art. 3:10). 2 financial years without a filing since the last one filed. Source: NBB filings, as of 3 November 2026.

Annual accounts 2023 filed on 30-08-2024 PDF all 2 filings

Equity
-€40,156▼ 56.8%
2022 · -€25,616
Total assets
€29,457▼ 6.4%
2022 · €31,477
Net result
-€14,540▲ 52.5%
2022 · -€30,616
Working capital
-€57,492▼ 25.6%
2022 · -€45,770
Multi-year overview
2022 to 2023, 2 financial years
Operating result
-€14,459
▲ 52.7% 2023
20222023
Net result
-€14,540
▲ 52.5% 2023
20222023
Equity
-€40,156
▼ 56.8% 2023
20222023
Total assets
€29,457
▼ 6.4% 2023
20222023
Debt
€69,612
▲ 21.9% 2023
20222023
Working capital
-€57,492
▼ 25.6% 2023
20222023
Every figure per financial year
Every figure with its change against the financial year before
favourable unfavourable
Line20222023
Operating result-€30,539--€14,459▲ 52.7%
Net result-€30,616--€14,540▲ 52.5%
Equity-€25,616--€40,156▼ 56.8%
Total assets€31,477-€29,457▼ 6.4%
Debt€57,093-€69,612▲ 21.9%
Working capital-€45,770--€57,492▼ 25.6%

The operating result for 2023 is a loss of €14,459, smaller than the loss of €30,539 in 2022.

Turnover and EBIT margin are not published. The micro format does not require them.

Balance-sheet composition
2023 in colour, 2022 as the grey bar beneath
Assets €29,457
Fixed assets €17,337 ▼ 14.0%
Current assets €12,120 ▲ 7.0%
Equity and liabilities
Equity-€40,156
Debt€69,612
Equity is negative. Debt (€69,612) exceeds the balance-sheet total (€29,457).
Key figures and ratios
2023 value · change against 2022
EBITDA
-€11,642▲
2022 · -€15,980
Cash flow
-€11,723▲
2022 · -€16,057
Solvency
-136.3%▼
2022 · -81.4%
Current ratio
0.17▼
2022 · 0.20
ROA
-49.4%▲
2022 · -97.3%
Interest coverage
-143.81▲
2022 · -207.61
Debt ≤ 1 year
€69,612▲
2022 · €57,093
Debt to equity is not shown because equity is negative. Debt divided by negative equity means nothing.
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.

Investments

fixed assets acquired
Item20222023
Intangible fixed assets€33,813-
Financial fixed assets€900-
Depreciation and write-downs of the year€14,559€2,817

Source: notes to the 2022 to 2023 annual accounts (statement of fixed assets)

Annual accounts
Filed annual accounts As filed with the NBB · 2023 against 2022 · 32 lines
Balance sheet Code20222023
Assets
Total assets20/58€31,477€29,457▼
Fixed assets21/28€20,154€17,337▼
Intangible fixed assets21€19,254€16,437▼
Financial fixed assets28€900€900=
Current assets29/58€11,323€12,120▲
Amounts receivable within one year40/41€11,323€10,472▼
Trade receivables40€9,155€10,159▲
Other amounts receivable41€2,168€313▼
Cash at bank and in hand54/58-€1,648
Equity and liabilities
Total equity and liabilities10/49€31,477€29,457▼
Equity10/15-€25,616-€40,156▼
Contributions10/11€5,000€5,000=
Profit (loss) carried forward14-€30,616-€45,156▼
Amounts payable17/49€57,093€69,612▲
Amounts payable within one year42/48€57,093€69,612▲
Financial debts43€4,510-
Credit institutions430/8€4,510-
Trade debts44€13,438€12,422▼
Suppliers440/4€13,438€12,422▼
Advances received on contracts in progress46€830-
Other amounts payable47/48€38,315€57,190▲
Income statement Code20222023
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14,559€2,817▼
Other operating charges640/8€62€2,390▲
Gross operating margin9900-€15,918-€9,252▲
Operating profit (loss)9901-€30,539-€14,459▲
Financial charges65/66B€77€81▲
Recurring financial charges65€77€81▲
Profit (loss) for the period before taxes9903-€30,616-€14,540▲
Profit (loss) for the period9904-€30,616-€14,540▲
Profit (loss) for the period to be appropriated9905-€30,616-€14,540▲
Appropriation of the result
Profit (loss) to be appropriated9906-€30,616-€45,156▼
Profit (loss) brought forward from the previous period14P--€30,616

The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2023 (PDF), filed on 30-08-2024.

Line20222023Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14,559€2,817▼ 80.6%
Other operating charges640/8€62€2,390▲ 39×
Gross operating margin9900-€15,918-€9,252▲ 41.9%
Operating profit (loss)9901-€30,539-€14,459▲ 52.7%
Financial charges65/66B€77€81▲ 5.2%
Recurring financial charges65€77€81▲ 5.2%
Profit (loss) for the period before taxes9903-€30,616-€14,540▲ 52.5%
Profit (loss) for the period9904-€30,616-€14,540▲ 52.5%
Profit (loss) for the period to be appropriated9905-€30,616-€14,540▲ 52.5%
Line20222023Change
Assets
Total assets20/58€31,477€29,457▼ 6.4%
Fixed assets21/28€20,154€17,337▼ 14.0%
Intangible fixed assets21€19,254€16,437▼ 14.6%
Financial fixed assets28€900€900=
Current assets29/58€11,323€12,120▲ 7.0%
Amounts receivable within one year40/41€11,323€10,472▼ 7.5%
Trade receivables40€9,155€10,159▲ 11.0%
Other amounts receivable41€2,168€313▼ 85.6%
Cash at bank and in hand54/58-€1,648-
Equity and liabilities
Total equity and liabilities10/49€31,477€29,457▼ 6.4%
Equity10/15-€25,616-€40,156▼ 56.8%
Contributions10/11€5,000€5,000=
Profit (loss) carried forward14-€30,616-€45,156▼ 47.5%
Amounts payable17/49€57,093€69,612▲ 21.9%
Amounts payable within one year42/48€57,093€69,612▲ 21.9%
Financial debts43€4,510--
Credit institutions430/8€4,510--
Trade debts44€13,438€12,422▼ 7.6%
Suppliers440/4€13,438€12,422▼ 7.6%
Advances received on contracts in progress46€830--
Other amounts payable47/48€38,315€57,190▲ 49.3%
Line20222023Change
Profit (loss) for the period9904-€30,616-€14,540▲ 52.5%
+ Depreciation and write-downs630€14,559€2,817▼ 80.6%
Operating cash flow (approximation)-€16,057-€11,723▲ 27.0%
Investment in fixed assets (approximation)-€0-

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (2)
Financial year Type Filed Reference Document
31-12-2023 micro format 30-08-2024 2024-00401715 PDF
31-12-2022 micro format 14-08-2023 2023-00327013 PDF

Board & ownership

Directors

Directors
1 director
RABEMANANTSOA ANDRY
Director · since 21-07-2021 · listed in the 2023 annual accounts, filed on 30-08-2024
Current

Owners and capital

Shareholders

Share transfer act of 03-01-2024 ↗
  • Mohamed Bouria to Annes Bouria
Stated in the act act of 26-01-2023 ↗
  • RABEMANANTSOA Andry all shares

Capital transactions

Capital over time
  1. 26-01-2023 Capital increase of €12,500 · to €52,500 · 100 new shares

Network & group

PharmaDEXI shares no director with another company.

Companies at the same address

12 other companies

Connections & network

1 current director
Depth

The network starts from the directors of PharmaDEXI. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Acts, filings and financial milestones

2024
30-08
NBB filing Annual accounts 2023 filedPDF
micro format · 30 days late
03-01
Gazette deed Capital & shares · Resignations & appointments
Share transfer4 points ▸
  • General meeting, 29-09-2023
  • Other provision, “actionnaire, démission comme actionnaire” (deed in French)
  • Other provision, “actionnaire, nomination comme actionnaire” (deed in French)
  • Share transfer, Mohamed Bouria → Annes Bouria

Open the act in the Belgian Official Gazette

2023
14-08
NBB filing Annual accounts 2022 filedPDF
micro format · 14 days late
26-01
Gazette deed Capital increase of €12,500 to €52,500
Shareholding · Power of attorney · Bank account19 points ▸
  • General meeting, 23-01-2023
  • RABEMANANTSOA Andry holds all the shares
  • Power of attorney, Michaelina de Radzitzky, mentioned 2 times in the deed
  • Other provision, “apport en espèces 12500 avec émission 100 actions nouvelles, souscription-libération” (deed in French)
  • Other provision, “expresse et irrévocable, justification du prix d'émission et conséquences sur droits patrimoniaux et sociaux” (deed in French)
  • Capital contribution, €12,500
  • Share issue, 100, “mêmes droits et avantages que actions existantes” (deed in French)
  • Other provision, “renonciation aux conditions d'admission des nouveaux actionnaires, CSA et article 9 des statuts” (deed in French)
  • Other provision, “à titre individuel et de manière expresse et irrévocable, renonciation au droit de préférence et délai d'exercice” (deed in French)
  • Other provision, “intégralité des apports complémentaires en numéraire, souscription” (deed in French)
  • Bank account, “CBC, BE92732067538323” (deed in French)
  • Other provision, “pacte d'actionnaires annexé, annexent à la présente un pacte d'actionnaires” (deed in French)
  • The act holds 7 more points.

Open the act in the Belgian Official Gazette

2021
19-07
Gazette deed IncorporationPDF
Gazette deedNBB filing

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

PharmaDEXI was incorporated on 15 July 2021 as a private limited company.1 In 2023 the capital was increased by €12,500 to €52,500.2 The company has filed 2 sets of annual accounts, the latest for financial year 2023.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 26-01-2023
  3. 3National Bank, annual accounts 2023

Company details

Register details

Identity

KBO record
Name PharmaDEXI in French
Enterprise number 0771.461.685
Legal form Private limited company
Status Active, normale toestand
Founded 15-07-2021
Entity type Legal entity

Registered office and establishments

Registered office Notarisstraat 64, 1050 Elsene, Belgium
Establishment unit PharmaDEXI, Notarisstraat 64, 1050 Elsene since 15-07-2021 · unit number 2.320.278.40446460 Wholesale of pharmaceutical and medical goods

Invoicing and payment

VAT number BE 0771.461.685
E-invoicing via Peppol
Not found in the Peppol Directory

This enterprise or VAT number is not in the Peppol Directory. Being listed there is voluntary, so the company can still receive invoices via Peppol.

Invoicing without a Peppol listing

Try sending from your invoicing software. If that fails, ask the customer whether they already receive via Peppol.

If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if you send it electronically, you need their agreement on a secure channel. The invoice remains valid; it is the customer, not you, who risks a penalty. FPS Finance

Follow this company and you will hear the next morning if it appears in the Peppol register.

Register as of 3 November 2026 · Peppol Directory

Financial year and general meeting

Accounts at the NBB
Financial year end 31-12

Sites & property

Location
registered office establishment The establishment unit on the map
13 companies at this address See who is registered here

Buildings and parcels at the address

Ground area
1,244 m²
Building footprint
389 m²
Building volume
3,638 m³
Cadastral parcel Region Area Buildings Height / floors
21447B0298/00W013 Brussels 1,244 m² 1 · 389 m² 19.6 m · 4